Compare MIRM & BOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIRM | BOX |
|---|---|---|
| Founded | 2018 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 5.8B |
| IPO Year | 2019 | 2014 |
| Metric | MIRM | BOX |
|---|---|---|
| Price | $92.00 | $42.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | ★ $157.71 | $44.71 |
| AVG Volume (30 Days) | 548.2K | ★ 2.4M |
| Earning Date | 11-03-2026 | 12-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.59 | N/A |
| EPS | N/A | ★ 0.18 |
| Revenue | $19,138,000.00 | ★ $506,142,000.00 |
| Revenue This Year | $37.65 | $9.58 |
| Revenue Next Year | $21.04 | $8.87 |
| P/E Ratio | ★ N/A | $243.61 |
| Revenue Growth | N/A | ★ 26.98 |
| 52 Week Low | $63.23 | $21.34 |
| 52 Week High | $130.00 | $44.89 |
| Indicator | MIRM | BOX |
|---|---|---|
| Relative Strength Index (RSI) | 52.45 | 58.99 |
| Support Level | $87.38 | $41.25 |
| Resistance Level | $98.34 | $44.89 |
| Average True Range (ATR) | 4.20 | 1.16 |
| MACD | 0.35 | -0.28 |
| Stochastic Oscillator | 48.74 | 49.06 |
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.